Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Medpace Stock Quote

Medpace (NASDAQ: MEDP)

$388.87
(0.4%)
$1.73
Price as of April 16, 2024, 1:48 p.m. ET

Medpace Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
MEDP +101.49% +614.81% +48.20% +1,281%
S&P +22.34% +74.52% +11.78% +132%

Medpace Company Info

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.